More ongoing research trials to validate HIPEC as a potential treatment for ovarian cancer.
The University Hospitals of Cleveland, Ohio recently started several new clinical trials to test the effectiveness of hyperthermic intra-peritoneal chemotherapy in women with ovarian and endometrial cancer. Unfortunately, the trials are small (around 60 woman) which means that even positive results will be far from definitive for researchers involved in the HIPEC debate. It also offers only limited opportunities for patients with ovarian cancer to receive potentially life-saving treatment.
Medpage recently published a nice overview on ovarian cancer and the current treatment modalities – which can be seen here.
More on HIPEC: here at Bogota Surgery: